| Volume: | 1,429,938 |
|---|---|
| Day's Low: | $39.82 |
| 52-wk Low: | $27.15 |
| Previous Close: | $40.46 |
| Dividend: | $0.49 |
| Market Cap: | 114,698,300 |
| Avg Volume: | 1,346,900 |
|---|---|
| Day's High: | $40.52 |
| 52-wk High: | $42.18 |
| Open Price: | $39.84 |
| Yield: | 4.84% |
| P/E (Forward): | 10.31 |
| 7:17 AM | 11/6/2009 | Aurobindo Pharma Gets Final US OK For Generic Epilepsy Drug |
| 7:17 AM | 11/6/2009 | GlaxoSmithKline: WHO Grants Prequalification For Synflorix |
| 6:08 PM | 11/5/2009 | Philadelphia Struggles With Transit Strike |
| 4:18 PM | 11/5/2009 | Wall St Firms Shouldn't Get Scarce Flu Shots, Nonprofit Says |
| 12:30 PM | 11/5/2009 | GlaxoSmithKline: James Murdoch Buys 1000 Shares At GBP12.23 |
| 11:24 AM | 11/5/2009 | 2nd UPDATE: Danish Biotech Genmab To Reorganize, Cut 300 Jobs |
| 10:21 AM | 11/5/2009 | UPDATE: Danish Biotech Genmab To Reorganize, Cut 300 Jobs |
| 11/5/2009 | Rail Strike Continues in Philadelphia |
| 11/3/2009 | What's Next for Warren Buffett After Railroad Deal |
| 11/3/2009 | Recapping 40,000 Job Cuts in Big Pharma |
| 11/2/2009 | Ford Cruises; Human Genome Soars |
| 11/2/2009 | Stocks Set to Bounce |
| 11/2/2009 | Stocks in the Spotlight Monday |
| 11/2/2009 | Human Genome, Vertex, Amylin in play |
| Most Recent Quarter ($) | Same Quarter Last Year ($) | % Change | |
| EPS, Pro Forma | 0.93 | NA | NA |
| EPS, GAAP | 0.00 | 0.71 | NA |
| Consensus Estimate | 0.96 | NA | NA |
| Trailing 12 Months | Year-Earlier Period | % Change | |
| EPS, Pro Forma | NA | 3.79 | NA |
| EPS, GAAP | 1.65 | 3.45 | -52.17 |
| Consensus Estimate | NA | NA | NA |
| GSK | Industry Average | |
| P/E (TTM) | 24.56 | 18.40 |
| P/E (Forward) | 10.31 | -4.30 |
| PEG Ratio | 2.50 | -0.28 |
| Price/Sales | 4.18 | 2.94 |
| Beta | 0.63 | 0.66 |